The system has an open architectural design to allow for third-party integrations.
Siemens Healthineers has announced that the FDA has cleared their latest installment of the ARTIS angiography system: ARTIS icono ceiling.
The ceiling-mounted system is designed for a range of interventional radiology and cardiology procedures as well as surgical procedures.
Enhancements to the system's C-arm allows for greater rotational capabilities and simplified cabling leading to cone beam CT acquisitions in 2.5 seconds at the head and 4 seconds at the right and left side of a patient's body. The short spin time both reduces motion artifacts and requires use of less contrast media.
“With the ARTIS icono ceiling, Siemens Healthineers combines excellent image quality and a previously unseen level of design flexibility to be the angiography system of choice for an unprecedented number of interventional radiology and cardiovascular procedures,” said Kris McVey, Vice President of Interventional Radiology and Cardiology at Siemens Healthineers North America, in a statement.
In addition, the system includes predefined Case Flow settings which can help improve overall efficiency and drive standardization within a health system. Benefits of the case flow settings include faster positioning and reduced patient radiation dose. Incorporation of the OPTIQ image chain also helps reduce patient dose while maintaining image quality, with the ARTIS system able to acquire and display images instantly with no loss in image quality.
Lastly, the open-architecture system allows for vendor-neutral integrations.
The ARTIS icono ceiling joins the ARTIS icono biplane and floor systems, which include capabilities with specific advantages for stroke treament and those with budget and space constraints, respectively.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.